DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,456 | +22.8% | 822 | +35.9% | 0.00% | – |
Q2 2023 | $8,518 | -8.9% | 605 | 0.0% | 0.00% | – |
Q1 2023 | $9,347 | -27.8% | 605 | -23.4% | 0.00% | – |
Q4 2022 | $12,948 | +1194.8% | 790 | +1419.2% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | – | 52 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 52 | +126.1% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 23 | +53.3% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 15 | -21.1% | 0.00% | – |
Q4 2019 | $1,000 | – | 19 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |